Back to ENTA
MARSHALL WACE, LLP ENTA Position History
Enanta Pharmaceuticals, Inc. • Healthcare
Quarters held
19
Latest value
$139K
Q2 2026
Peak value
$16.6M
First seen
Q3 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2023 | $836K |
| Q1 2024 | $16.6M |
| Q2 2024 | $12M |
| Q3 2024 | $8.8M |
| Q4 2024 | $4.9M |
| Q4 2024 | $41K |
| Q4 2024 | $414K |
| Q1 2025 | $4.7M |
| Q2 2025 | $6.4M |
| Q2 2025 | $49K |
| Q3 2025 | $2.2M |
| Q3 2025 | $1.1M |
| Q4 2025 | $3.4M |
| Q4 2025 | $2.7M |
| Q1 2026 | $2.1M |
| Q1 2026 | $589K |
| Q2 2026 | $39K |
| Q2 2026 | $1.7M |
| Q2 2026 | $139K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $139K | 9.5K | — | — |
| Q2 2026 | $1.7M | 119.8K | — | — |
| Q2 2026 | $39K | 2.7K | — | — |
| Q1 2026 | $589K | 46.6K | — | — |
| Q1 2026 | $2.1M | 163.5K | — | — |
| Q4 2025 | $2.7M | 172.2K | — | — |
| Q4 2025 | $3.4M | 213.1K | — | — |
| Q3 2025 | $1.1M | 89.8K | — | — |
| Q3 2025 | $2.2M | 185.6K | — | — |
| Q2 2025 | $49K | 6.5K | — | — |
| Q2 2025 | $6.4M | 850.9K | — | — |
| Q1 2025 | $4.7M | 850.9K | — | — |
| Q4 2024 | $414K | 72.1K | — | — |
| Q4 2024 | $41K | 7.1K | — | — |
| Q4 2024 | $4.9M | 850.9K | — | — |
| Q3 2024 | $8.8M | 850.9K | — | — |
| Q2 2024 | $12M | 928.4K | — | — |
| Q1 2024 | $16.6M | 951.1K | — | — |
| Q3 2023 | $836K | 74.8K | — | — |
Other funds holding ENTA
$33.4M